Letter from the Divisional Director

Dear Esteemed Colleagues,

The weight of delivering life-saving treatments to patients rests squarely on our shoulders. Selecting the right Contract Manufacturing Organization partner is a pivotal decision that can significantly impact our ability to bring high-quality medications to market.

However, the landscape is dynamic and complex, influenced by geopolitical tensions, technological advancements, and increasing sustainability demands. How can we adapt our selection criteria to navigate these challenges effectively? And how can we foster transparent, collaborative, and innovative partnerships with our chosen CMOs to thrive in this evolving environment?

To address these critical questions, Pharma IQ is excited to invite you to Pharma Contract Manufacturing 2025, a two-day interactive summit in Berlin designed to be your strategic partnership powerhouse.

Join us from March 26-27 as we delve into key topics, including:

• Partner Selection: Learn how to identify the ideal CMO/CDMO partner in a rapidly changing market. Hear from pharmaceutical and CMO leaders about essential selection criteria and effective contract negotiation strategies.
• Cost Management: Discover strategies for managing costs efficiently while ensuring operational transparency in a fluctuating market environment.
• Digital Transformation: Explore how advancements in automation, AI, and data analytics are transforming contract manufacturing.
• Sustainability: Learn how to incorporate environmentally sustainable practices into your partnerships.
• Regulatory Compliance: Understand the implications of the Biosecure Act and how to overcome regulatory challenges.
• Conflict Zones: Gain insights into best practices for collaborating on drug delivery in conflict-affected regions.

Remember, patient success hinges on our collective success. Join us in Berlin as we chart a course for stronger, more strategic partnerships that will empower us to reach new heights in patient care.

Sincerely,